{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:57:32Z","timestamp":1790431052154,"version":"4.1.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"65","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,12]]},"DOI":"10.18632\/oncotarget.20585","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T01:50:33Z","timestamp":1504057833000},"page":"108624-108642","source":"Crossref","is-referenced-by-count":32,"title":["Improving anti-melanoma effect of curcumin by biodegradable nanoparticles"],"prefix":"10.18632","volume":"8","author":[{"given":"Bilan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, West China Second university Hospital, Sichuan University, Chengdu, PR China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second university Hospital, Sichuan University, Chengdu, PR China"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, PR China"},{"name":"Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center, Chengdu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncolo, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China"},{"name":"Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center, Chengdu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Teng","sequence":"additional","affiliation":[{"name":"Research Unit of Infection and Immunity, Department of Pathophysiology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[{"name":"Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center, Chengdu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Chen","sequence":"additional","affiliation":[{"name":"Research Unit of Infection and Immunity, Department of Pathophysiology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Hu","sequence":"additional","affiliation":[{"name":"Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center, Chengdu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[{"name":"Research Unit of Infection and Immunity, Department of Pathophysiology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, China"},{"name":"Puyang Medical College, Puyang, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Second university Hospital, Sichuan University, Chengdu, PR China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second university Hospital, Sichuan University, Chengdu, PR China"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, PR China"},{"name":"Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center, Chengdu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmei","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology, West China Second university Hospital, Sichuan University, Chengdu, PR China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second university Hospital, Sichuan University, Chengdu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"He","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","article-title":"Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis","volume":"21","author":"Carvajal","year":"2016","journal-title":"Oncologist"},{"key":"4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10555-014-9542-0","article-title":"Immunotherapy of melanoma: present options and future promises","volume":"34","author":"McElwee","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"5","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Maio","year":"2011","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.molmed.2015.05.005","article-title":"Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system","volume":"21","author":"Kiessling","year":"2015","journal-title":"Trends Mol Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s40265-014-0305-6","article-title":"Clinical impact of checkpoint inhibitors as novel cancer therapies","volume":"74","author":"Infante","year":"2014","journal-title":"Drugs"},{"key":"8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejca.2015.09.013","article-title":"Survival of patients with advanced metastatic melanoma: The impact of novel therapies","volume":"53","author":"Schadendorf","year":"2016","journal-title":"Eur J Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Lorigan","year":"2015","journal-title":"Lancet Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.18632\/oncotarget.2980","article-title":"PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma","volume":"6","author":"Ott","year":"2015","journal-title":"Oncotarget"},{"key":"11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamaoncol.2015.4368","article-title":"Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders","volume":"2","author":"Bender","year":"2016","journal-title":"JAMA Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-related adverse events with immune checkpoint blockade: a comprehensive review","volume":"54","author":"Ribrag","year":"2016","journal-title":"Eur J Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Wolchok","year":"2015","journal-title":"Ann Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.trsl.2015.06.005","article-title":"Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma","volume":"166","author":"Agrawal","year":"2015","journal-title":"Transl Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"9862","DOI":"10.1038\/srep09862","article-title":"Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant alpha-Synuclein","volume":"5","author":"Gupta","year":"2015","journal-title":"Sci Rep"},{"key":"16","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1021\/acs.accounts.5b00127","article-title":"Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity","volume":"48","author":"Chakravarty","year":"2015","journal-title":"Acc Chem Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1016\/j.biomaterials.2013.12.090","article-title":"Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment","volume":"35","author":"Hennink","year":"2014","journal-title":"Biomaterials"},{"key":"18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jconrel.2015.04.025","article-title":"Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer","volume":"209","author":"Nagasaki","year":"2015","journal-title":"J Control Release"},{"key":"19","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/bjc.2015.359","article-title":"Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling","volume":"113","author":"Troiani","year":"2015","journal-title":"Br J Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biocel.2016.02.014","article-title":"Curcumin-treated cancer cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype","volume":"74","author":"Sikora","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"21","doi-asserted-by":"publisher","first-page":"10322","DOI":"10.1038\/srep10322","article-title":"Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo","volume":"5","author":"Gong","year":"2015","journal-title":"Sci Rep"},{"key":"22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2014.11.028","article-title":"Curcumin promotes apoptosis by activating the p53-miR-192-5p\/215-XIAP pathway in non-small cell lung cancer","volume":"357","author":"Zhang","year":"2015","journal-title":"Cancer Lett"},{"key":"23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2015.11.021","article-title":"Curcumin induces apoptosis by inhibiting sarco\/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells","volume":"371","author":"Song","year":"2016","journal-title":"Cancer Lett"},{"key":"24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","article-title":"Curcumin effectively inhibits oncogenic NF-kappaB signaling and restrains stemness features in liver cancer","volume":"63","author":"Factor","year":"2015","journal-title":"J Hepatol"},{"key":"25","doi-asserted-by":"publisher","first-page":"13429","DOI":"10.1038\/srep13429","article-title":"Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1","volume":"5","author":"Fan","year":"2015","journal-title":"Sci Rep"},{"key":"26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.canlet.2014.12.007","article-title":"Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer","volume":"357","author":"El-Rayes","year":"2015","journal-title":"Cancer Lett"},{"key":"27","doi-asserted-by":"publisher","first-page":"40680","DOI":"10.18632\/oncotarget.5673","article-title":"Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways","volume":"6","author":"Ellerkamp","year":"2015","journal-title":"Oncotarget"},{"key":"28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2217\/nnm.12.80","article-title":"Advances in nanotechnology-based delivery systems for curcumin","volume":"7","author":"Zhai","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/nutrit\/nuu064","article-title":"Curcumin and cancer: barriers to obtaining a health claim","volume":"73","author":"Jones","year":"2015","journal-title":"Nutr Rev"},{"key":"30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.biomaterials.2012.08.072","article-title":"pH-sensitive poly(histidine)-PEG\/DSPE-PEG co-polymer micelles for cytosolic drug delivery","volume":"34","author":"Torchilin","year":"2013","journal-title":"Biomaterials"},{"key":"31","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform","volume":"2","author":"Farokhzad","year":"2008","journal-title":"ACS Nano"},{"key":"32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG - a versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Misra","year":"2014","journal-title":"J Control Release"},{"key":"33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2014.03.026","article-title":"PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications","volume":"183","author":"He","year":"2014","journal-title":"J Control Release"},{"key":"34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0168-3659(96)01510-6","article-title":"Release of taxol from poly( \u03f5 -caprolactone) pastes: effect of water-soluble additives","volume":"44","author":"Burt","year":"1997","journal-title":"Journal of Controlled Release"},{"key":"35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2007.08.030","article-title":"In vitro and in vivo test of PEG\/PCL-based hydrogel scaffold for cell delivery application","volume":"124","author":"Park","year":"2007","journal-title":"J Control Release"},{"key":"36","doi-asserted-by":"publisher","first-page":"10985","DOI":"10.1021\/am4032295","article-title":"Thermo-induced shape-memory PEG-PCL copolymer as a dual-drug-eluting biodegradable stent","volume":"5","author":"Wang","year":"2013","journal-title":"ACS Appl Mater Interfaces"},{"key":"37","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1021\/la062512i","article-title":"Synthesis and self-assembly of amphiphilic polymeric microparticles","volume":"23","author":"Doyle","year":"2007","journal-title":"Langmuir"},{"key":"38","doi-asserted-by":"publisher","first-page":"9660","DOI":"10.1021\/la900734d","article-title":"Supramolecular assemblies of amphiphilic homopolymers","volume":"25","author":"Thayumanavan","year":"2009","journal-title":"Langmuir"},{"key":"39","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1039\/C3TB21091J","article-title":"Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles","volume":"1","author":"Wei","year":"2013","journal-title":"Journal of Materials Chemistry B"},{"key":"40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5681\/apb.2014.074","article-title":"Biodegradable m-PEG\/PCL Core-Shell Micelles: Preparation and Characterization as a Sustained Release Formulation for Curcumin","volume":"4","author":"Hamidi","year":"2014","journal-title":"Adv Pharm Bull"},{"key":"41","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","article-title":"Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer","volume":"35","author":"Chauhan","year":"2014","journal-title":"Biomaterials"},{"key":"42","doi-asserted-by":"publisher","first-page":"26535","DOI":"10.18632\/oncotarget.8532","article-title":"Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"43","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.3390\/nu5093367","article-title":"Flavonoid bioavailability and attempts for bioavailability enhancement","volume":"5","author":"Rupasinghe","year":"2013","journal-title":"Nutrients"},{"key":"44","doi-asserted-by":"publisher","first-page":"7700","DOI":"10.1021\/jf505848z","article-title":"Isolation of Luteolin and Luteolin-7-O-glucoside from Dendranthema morifolium Ramat Tzvel and Their Pharmacokinetics in Rats","volume":"63","author":"Tsai","year":"2015","journal-title":"J Agric Food Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:04:22Z","timestamp":1589209462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":44,"journal-issue":{"issue":"65","published-print":{"date-parts":[[2017,12,12]]}},"alternative-id":["20585","29312556"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20585","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}